6 x ROHM Aromasin 25mg x 50

Description

Classification

Product: 6 x ROHM Aromasin 25mg x 50
Common active ingredient: Exemestane
Common brand name: Aromasin
Product class: Aromatase inhibitor
Stated strength: 25mg
Pack size: 50 units
Bulk quantity: 6 packs
Total stated units: 300

Aromasin is the established brand name for exemestane, a steroidal aromatase inhibitor. Current UK medicines information lists Aromasin and several generic exemestane 25mg products.

The specific formulation, manufacturer specifications and regulatory status of 6 x ROHM Aromasin 25mg x 50 should be verified from the original product packaging and documentation.

What is 6 x ROHM Aromasin 25mg x 50?

6 x ROHM Aromasin 25mg x 50 is a bulk product identified as Aromasin 25mg, commonly associated with the active ingredient exemestane.

Exemestane is a steroidal aromatase inhibitor that reduces the body’s production of oestrogen. Its established UK medical use is primarily in postmenopausal women with hormone-dependent breast cancer.

The current UK-authorised Aromasin product is prescription-only and has defined indications, dosing instructions and safety requirements. These details should not automatically be transferred to the specific ROHM product without verifying its formulation and regulatory status.

Dosage

For the current UK-authorised Aromasin 25mg product, the recommended adult dose is one 25mg tablet once daily, preferably after a meal, for the authorised indications.

However, this authorised regimen should not automatically be presented as the approved dosage for 6 x ROHM Aromasin 25mg x 50, because the specific ROHM product has not been independently verified as an authorised UK medicine.

Exemestane should be used under appropriate medical supervision. It is not appropriate to provide an unsupervised aromatase-inhibitor regimen for bodybuilding, steroid-cycle management or self-directed hormone manipulation.

How Does ROHM Aromasin Work?

Exemestane works by inhibiting the enzyme aromatase, which is involved in converting androgen hormones into oestrogens.

It is a steroidal, irreversible aromatase inhibitor. By reducing aromatase activity, exemestane lowers circulating oestrogen concentrations.

This reduction is therapeutically useful in hormone-dependent breast cancer, where oestrogen can stimulate the growth of certain tumour cells.

Benefits

For its authorised medical use, potential benefits of exemestane include:

• Reduction of circulating oestrogen
• Hormonal treatment of oestrogen-dependent breast cancer
• Adjuvant treatment following an appropriate course of tamoxifen
• Treatment of advanced hormone-dependent breast cancer after progression on previous anti-oestrogen therapy

Current UK product information specifies use in postmenopausal women with hormone-dependent early or advanced breast cancer.

Exemestane is sometimes discussed in relation to controlling oestrogen during anabolic-steroid use. Such use should not be confused with its established UK therapeutic indications.

When Should You Not Take Aromasin?

Exemestane should not be taken by people with a known hypersensitivity to exemestane or any ingredient in the relevant formulation.

Current UK product information contraindicates exemestane in:

• Pre-menopausal women
• Pregnant women
• Breast-feeding women
• People with known hypersensitivity to the active substance or excipients

Postmenopausal status should be appropriately established before treatment where clinically necessary.

Particular caution is required in people with liver or kidney impairment and those with reduced bone mineral density or osteoporosis.

Mechanism

Exemestane is a steroidal aromatase inhibitor.

Aromatase converts certain androgens into oestrogens. Exemestane binds to the aromatase enzyme and produces sustained inhibition of oestrogen biosynthesis.

Lower oestrogen levels can reduce hormonal stimulation of oestrogen-sensitive breast cancer cells, which is the basis for its use in postmenopausal hormone-dependent breast cancer.

Because oestrogen also has important physiological roles in bone and other tissues, excessive oestrogen suppression can produce clinically significant adverse effects.

Uses

Current UK-authorised exemestane products are indicated for specific breast-cancer treatment settings.

These include:

• Adjuvant treatment of postmenopausal women with oestrogen-receptor-positive early breast cancer following 2–3 years of tamoxifen
• Continued adjuvant hormonal treatment to complete an appropriate treatment programme
• Treatment of advanced breast cancer in postmenopausal women following progression after anti-oestrogen therapy

6 x ROHM Aromasin 25mg x 50 should not be marketed as an approved treatment for bodybuilding, post-cycle therapy or prevention of anabolic-steroid side effects unless its specific regulatory status and indication have been established.

Warnings and Precautions

Exemestane is a potent oestrogen-lowering medicine, so prolonged treatment can affect bone health.

Important considerations include:

• Reduction in bone mineral density
• Increased risk of osteoporosis
• Increased fracture risk
• Vitamin D deficiency
• Liver impairment
• Kidney impairment
• Possible interactions with enzyme-inducing medicines

UK product information recommends assessment of bone health in patients at risk of osteoporosis and highlights the importance of vitamin D assessment where appropriate.

Exemestane should not be combined with oestrogen-containing medicines because they can counteract its pharmacological action.

Certain CYP3A4-inducing medicines, including rifampicin, phenytoin and carbamazepine, can reduce exemestane exposure and potentially reduce its effectiveness. St John’s Wort can also affect CYP3A4 activity.

Side Effects

Possible adverse effects associated with exemestane include:

• Hot flushes
• Sweating
• Joint or muscle pain
• Headache
• Tiredness
• Dizziness
• Difficulty sleeping
• Nausea
• Abdominal discomfort
• Loss of appetite
• Hair loss
• Skin rash or itching
• Weakness
• Osteoporosis and fractures
• Swelling of the hands or feet
• Changes in liver enzymes

Less common or rare reactions can include hypersensitivity, liver inflammation and bile-duct inflammation.

Because exemestane lowers oestrogen, long-term treatment can have a meaningful effect on bone strength.

Storage

Storage requirements for 6 x ROHM Aromasin 25mg x 50 should be followed exactly as stated on the specific product packaging.

For comparison, authorised exemestane products have defined storage requirements supplied in their individual product information. The ROHM product should not automatically be assumed to have identical storage specifications.

General precautions include:

• Keep in the original packaging.
• Protect from excessive heat and moisture.
• Keep out of reach of children.
• Keep the container properly closed.
• Do not use damaged packaging.
• Do not use beyond the stated expiry date.

Where to Buy 6 x ROHM Aromasin 25mg x 50?

To get 6 x ROHM Aromasin 25mg x 50 online, go to Steroid Sanctuary today to get the best deal on this medicine.

Frequently Asked Questions

1. What is 6 x ROHM Aromasin 25mg x 50?

It is a bulk product identified as Aromasin 25mg, commonly associated with the active ingredient exemestane. The supplied quantity is six packs containing 50 units each, giving a stated total of 300 units.

2. What is Aromasin?

Aromasin is the brand name associated with exemestane, a steroidal aromatase inhibitor that reduces the production of oestrogen.

3. What is exemestane used for?

Authorised UK exemestane medicines are used primarily for hormone-dependent breast cancer in postmenopausal women, including certain early and advanced breast-cancer treatment settings.

4. What are the important side effects of Aromasin?

Important potential adverse effects include hot flushes, joint or muscle pain, tiredness, dizziness, hair loss and reduced bone mineral density. Long-term oestrogen suppression can increase the risk of osteoporosis and fractures.

5. Is 6 x ROHM Aromasin 25mg x 50 authorised in the UK?

The specific regulatory status of this ROHM product should be verified independently. Current UK medicines information confirms authorised Aromasin and generic exemestane 25mg products, but this does not establish that a particular ROHM product carries the same UK marketing authorisation.